MOPP regimen: Difference between revisions
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a chemotherapy regimen consisting of [[mechlorethamine]], [[vincristine|vincristine (Oncovin)]], [[procarbazine]] and [[prednisone]], used alone or in combination with radiation therapy for the treatment of stage I-IV [[Hodgkin lymphoma]]. Due to the increased risk of gonadal toxicity, this regimen has been widely replaced by the ABVD regimen.<ref name="pmid23814851">{{cite journal| author=Filatova LV, Plotnikova AA, Gershanovich ML, Semiglazova TIu| title=[Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis]. | journal=Vopr Onkol | year= 2013 | volume= 59 | issue= 2 | pages= 59-65 | pmid=23814851 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23814851 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C9619&ns=NCI_Thesaurus }}</ref> | {{PAGENAME}} refers to a chemotherapy regimen consisting of [[mechlorethamine]], [[vincristine|vincristine (Oncovin)]], [[procarbazine]] and [[prednisone]], used alone or in combination with radiation therapy for the treatment of stage I-IV [[Hodgkin lymphoma]]. Due to the increased risk of gonadal toxicity, this regimen has been widely replaced by the ABVD regimen.<ref name="pmid23814851">{{cite journal| author=Filatova LV, Plotnikova AA, Gershanovich ML, Semiglazova TIu| title=[Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis]. | journal=Vopr Onkol | year= 2013 | volume= 59 | issue= 2 | pages= 59-65 | pmid=23814851 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23814851 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C9619&ns=NCI_Thesaurus }}</ref> | ||
==Regimen== | ==Regimen== | ||
Latest revision as of 18:08, 27 March 2015
|
WikiDoc Resources for MOPP regimen |
|
Articles |
|---|
|
Most recent articles on MOPP regimen Most cited articles on MOPP regimen |
|
Media |
|
Powerpoint slides on MOPP regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on MOPP regimen at Clinical Trials.gov Clinical Trials on MOPP regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on MOPP regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on MOPP regimen Discussion groups on MOPP regimen Patient Handouts on MOPP regimen Directions to Hospitals Treating MOPP regimen Risk calculators and risk factors for MOPP regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for MOPP regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: Mechlorethamine/Prednisone/Procarbazine/Vincristine Regimen; MOPP; MOPP Regimen; MOPP regimen; Mustargen-Oncovin-Procarbazine-Prednisone Regimen; NM/PCB/PRED/VCR
Overview
MOPP regimen refers to a chemotherapy regimen consisting of mechlorethamine, vincristine (Oncovin), procarbazine and prednisone, used alone or in combination with radiation therapy for the treatment of stage I-IV Hodgkin lymphoma. Due to the increased risk of gonadal toxicity, this regimen has been widely replaced by the ABVD regimen.[1][2]
Regimen
MMechlorethamine
OVincristine (Oncovin)
PProcarbazine
PPrednisone
Indications
- Stage I-IV Hodgkin lymphoma[1][3]
References
- ↑ 1.0 1.1 Filatova LV, Plotnikova AA, Gershanovich ML, Semiglazova TIu (2013). "[Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis]". Vopr Onkol. 59 (2): 59–65. PMID 23814851.
- ↑ "NCI Thesaurus".
- ↑ "NCI Thesaurus".